Notch Therapeutics Closes $85M Series A Financing

15 Feb, 2021

Notch Therapeutics Closes $85M Series A Financing
Photo by XPS on Unsplash

– Notch Therapeutics is a Vancouver, BC-based biotechnology company developing renewable, induced pluripotent stem cell (iPSC)-derived cell therapies for cancer.
– Company closed an U.S. $85m Series A financing.
– The round was led by an exclusively healthcare-focused investment fund with participation from existing investors Allogene Therapeutics, Inc., Lumira Ventures, and CCRM Enterprises Holdings Ltd., an affiliate of Centre for Commercialization of Regenerative Medicine (CCRM); along with new investors EcoR1 Capital, Casdin Capital, Samsara BioCapital, and Amplitude Ventures.

Biotechnology Developer Platform Health Care North America

Related Posts

Infrastructure-as-code management platform Spacelift nabs $15M

Infrastructure-as-code management platform Spacelift nabs $15M

16 Oct, 2021
Cannabis tech startup Dutchie raises $350M to double valuation to $3.75B in less than a year

Cannabis tech startup Dutchie raises $350M to double valuation to $3.75B in less than a year

16 Oct, 2021
Geospatial analytics startup AiDash lands $27M

Geospatial analytics startup AiDash lands $27M

16 Oct, 2021
Space Perspective raises $40M for balloons that can take people into space

Space Perspective raises $40M for balloons that can take people into space

16 Oct, 2021

Crunchbase icon

Content report

The following text will be sent to our editors:

Send